Technical Analysis for IMNM - Immunome, Inc.

Grade Last Price % Change Price Change
D 29.72 -2.24% -0.68
IMNM closed down 2.24 percent on Monday, April 12, 2021, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Flat Down
Historical IMNM trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -2.24%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.24%
Narrow Range Bar Range Contraction -2.24%
Multiple of Ten Bullish Other -2.24%
Older End-of-Day Signals for IMNM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 8 hours ago
Down 2 % about 8 hours ago
Down 1% about 8 hours ago
Fell Below Previous Day's Low about 8 hours ago
Up 2% 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibody Monoclonal Antibodies Cancer Immunotherapy Antibody Multiplex Tumor Glycoproteins Antigen

Is IMNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 63.78
52 Week Low 9.27
Average Volume 322,908
200-Day Moving Average 0.00
50-Day Moving Average 29.84
20-Day Moving Average 31.96
10-Day Moving Average 31.14
Average True Range 3.15
ADX 32.26
+DI 26.70
-DI 17.80
Chandelier Exit (Long, 3 ATRs ) 32.22
Chandelier Exit (Short, 3 ATRs ) 37.63
Upper Bollinger Band 36.24
Lower Bollinger Band 27.67
Percent B (%b) 0.24
BandWidth 26.81
MACD Line 0.10
MACD Signal Line 0.65
MACD Histogram -0.5482
Fundamentals Value
Market Cap 313.3 Million
Num Shares 10.5 Million
EPS
Price-to-Sales 0.00
Price-to-Book 12.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.16
Resistance 3 (R3) 31.25 30.85 30.92
Resistance 2 (R2) 30.85 30.49 30.81 30.84
Resistance 1 (R1) 30.29 30.26 30.09 30.20 30.76
Pivot Point 29.89 29.89 29.80 29.85 29.89
Support 1 (S1) 29.33 29.53 29.13 29.24 28.68
Support 2 (S2) 28.93 29.30 28.89 28.60
Support 3 (S3) 28.37 28.93 28.52
Support 4 (S4) 28.28